22 June 2018 | News
Beckman Coulter Diagnostics will access UCI research in innovative diagnostic platforms.
Beckman Coulter Diagnostics, a global leader in the clinical diagnostics industry, has embarked on a strategic collaboration with the University of California, Irvine (UCI), one of the first targeted academic partnerships the company envisions around the globe.
Beckman Coulter Diagnostics will access UCI research in innovative diagnostic platforms, life sciences applications, devices, and data analytics to further its mission of advancing healthcare. UCI faculty, students and entrepreneurs will benefit from Beckman Coulter Diagnostics' expertise in accelerating the commercialization of technology and other world-class UCI breakthroughs.
As a first step, Beckman Coulter will fund Proof of Product grants to help UCI’s innovations bridge the gap between the lab and early commercialization. Through these grants, Beckman Coulter will determine a specific focus area for university entrepreneurial teams. Additionally, Beckman Coulter will also seek eligible UCI graduate students to enter its competitive talent onboarding program, in which they will get the opportunity to work across multiple divisions of the company.